FDA Warning Letter — Strive Pharmacy Texas LLC dba Strive Pharmacy

Case 639220 — FEI 3015826784

The FDA took a Warning Letter action against Strive Pharmacy Texas LLC dba Strive Pharmacy on August 30, 2022 (Boerne, TX). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Strive Pharmacy Texas LLC dba Strive Pharmacy
Date
August 30, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Boerne, TX (United States)